Thursday, March 05, 2026

Tonix Pharma CEO talks about the worldwide licensing agreement for its anti-viral COVID inhibitor.

Apr 30, 2021

Click the Subscribe button for the latest in crypto, blockchain and business news from NEW TO THE STREET!

See the full episode at: https://newtothestreet.com/new-to-the-street-april-25-2021-gcac-tonix-pharmaceuticals-healixa-petproductscom-finxflo-nativecoin-the-nifty-show

Tonix Pharmaceuticals (NASDAQ: TNXP) (Tonix) is a clinical-stage biopharmaceutical company committed to discovering and developing innovative and proprietary new therapeutics that address the needs of patients. Seth Lederman, M.D., President and Chief Executive Officer talks about their exclusive worldwide licensing agreement for its anti-viral COVID inhibitor.

#crypto #cryptocurrency #financialnews #newtothestreet #exploringtheblock #blockchain #blockchainnews #digitalcurrency #businessnews #newsmaxtv #tonixpharma #covid